BioPorto

BIOPOR Nasdaq Copenhagen LEI 5299004SWFL5JAN4W830
Follow BioPorto Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2026 DKK · IFRS
Revenue, last year DKK 40.3M
Net income −DKK 82.1M
EPS, diluted −DKK 0.18
Operating cash flow −DKK 77.1M
Revenue by fiscal year
DKK 31M
DKK 36.2M
DKK 40.3M
FY23 FY24 FY26

Source: ESEF annual reports · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income4 fiscal years
  • Revenue
  • Net income
−DKK 100M−DKK 50MDKK 0DKK 50MFY23FY24FY25FY26
Show the numbers
YearRevenueNet income
FY26DKK 40.3M−DKK 82.1M
FY25--
FY24DKK 36.2M−DKK 68.2M
FY23DKK 31M−DKK 56.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−300%−200%−100%0%100%FY23FY24FY25FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2675.4%−213.7%−203.8%
FY25---
FY2467.7%−208.2%−188.3%
FY2365.2%−197.6%−181.9%
Free cash flowOperating cash flow minus capital expenditure
−DKK 100M−DKK 75M−DKK 50M−DKK 25MDKK 0FY23FY24FY25FY26
Show the numbers
YearFree cash flow
FY26−DKK 77.1M
FY25-
FY24−DKK 83.9M
FY23−DKK 55.5M